1 results match your criteria: "The First Clinical Hospital of Medicine School of South China University of Technology[Affiliation]"
[Lymphocyte Count before First Consolidation Therapy Is A Predictor of Relapse free Survival in Acute Myeloid Leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
August 2018
Department of Hematology, Guangdong People Hospital/ Guangdong Academy of Medical Sciences, The First Clinical Hospital of Medicine School of South China University of Technology,Guangzhou 510080, Guangdong Province, China.
Objective: To investigate the effects of absolute lymphocyte count(ALC) before start of the first cycle of consolidation chemotherapy(CC) on the relapse free survival in the patients with acute myeloid leukemia(AML), so as to explore a simple and easy method for predicting AML relapse.
Methods: The clinical data of 132 patients with newly diagnosed AML (all non-acute promyelotic leukemia) from 2011 to 2017 were analyzed retrospectively. The 132 AML patients were treated with standard induction chemotherapy (IC) and consolidation chemotherapy (CC).